Brightseed has announced the launch of the Brightseed Innovation Platform, which it calls the "first continuous, AI-powered Health Sciences Innovation Platform designed to increase the probability of commercial success across health and life sciences."
The launch means that Brightseed is now a platform-based enterprise AI company delivering software- and data-as-a-service (Saas and Daas) to global health science organisations, evolving from its discovery-focused bioactives roots.
Speaking exclusively to Manufacturing Chemist, Brightseed explained how the platform reduces formulation and manufacturing challenges: "Brightseed's platform supports decisions related to bioavailability and sourcing by capturing data such as ADME predictions, geographic origin and plant-part sourcing within its database."
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.